Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Kench

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Artificial Organs|August 5, 2022
Long-term normothermic perfusion of human livers for longer than 12 daysNgee-Soon Lau, Mark Ly, Claude Dennis, et al.
Pathology Research International|December 29, 2010
Retroperitoneal inflammatory liposarcoma in a patient with non-hodgkin lymphoma: a report highlighting diagnostic pitfallsCathy S Lim, Caroline L Cooper, Warick Delprado, et al.
Hepatology International|July 24, 2015
Oxidative stress is closely associated with insulin resistance in genotypes 1 and 3 chronic hepatitis CSaid M Hashemi, David van der Poorten, Francisco Barrera, et al.
Journal of Gastroenterology and Hepatology|August 8, 2002
Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infectionJason M Hui, James Kench, Geoffrey C Farrell, et al.
Australasian Radiology|June 5, 2003
Transjugular liver biopsy effecting changes in clinical managementDavid Lee, Shivakumar Chitturi, James Kench, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2005
Antioxidant levels in peripheral blood, disease activity and fibrotic stage in chronic hepatitis CPriyanka Bandara, Jacob George, Geoffrey McCaughan, et al.
Hepatology (Baltimore, Md.)|June 27, 2002
HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severityShivakumar Chitturi, Martin Weltman, Geoffrey C Farrell, et al.
Pathology|December 9, 2023
Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patientsHemamali Samaratunga, Lars Egevad, John Yaxley, et al.
Clinical Chemistry|August 2, 2005
Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infectionLeon A Adams, Max Bulsara, Enrico Rossi, et al.
The American Journal of Gastroenterology|June 24, 2003
Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progressionShirley A Coverdale, Dev A Samarasinghe, Rita Lin, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Artificial Organs|August 5, 2022
Long-term normothermic perfusion of human livers for longer than 12 daysNgee-Soon Lau, Mark Ly, Claude Dennis, et al.
Pathology Research International|December 29, 2010
Retroperitoneal inflammatory liposarcoma in a patient with non-hodgkin lymphoma: a report highlighting diagnostic pitfallsCathy S Lim, Caroline L Cooper, Warick Delprado, et al.
Hepatology International|July 24, 2015
Oxidative stress is closely associated with insulin resistance in genotypes 1 and 3 chronic hepatitis CSaid M Hashemi, David van der Poorten, Francisco Barrera, et al.
Journal of Gastroenterology and Hepatology|August 8, 2002
Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infectionJason M Hui, James Kench, Geoffrey C Farrell, et al.
Australasian Radiology|June 5, 2003
Transjugular liver biopsy effecting changes in clinical managementDavid Lee, Shivakumar Chitturi, James Kench, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2005
Antioxidant levels in peripheral blood, disease activity and fibrotic stage in chronic hepatitis CPriyanka Bandara, Jacob George, Geoffrey McCaughan, et al.
Hepatology (Baltimore, Md.)|June 27, 2002
HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severityShivakumar Chitturi, Martin Weltman, Geoffrey C Farrell, et al.
Pathology|December 9, 2023
Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patientsHemamali Samaratunga, Lars Egevad, John Yaxley, et al.
Clinical Chemistry|August 2, 2005
Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infectionLeon A Adams, Max Bulsara, Enrico Rossi, et al.
The American Journal of Gastroenterology|June 24, 2003
Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progressionShirley A Coverdale, Dev A Samarasinghe, Rita Lin, et al.
Pageof 4